Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Recursion Pharmaceuticals
(RXRX.MX) Q2 2025
Earnings
RXRX.MX
May 5
Confirmed
Q4 2024
Q1 2025
Q2 2025
-10.88
-9.5
-8.11
-6.73
Details
Expected EPS
-10.1496684
Actual EPS
-9.83495
Surprise EPS
0.31
Surprise Percent
+3.1%
Description
Recursion Pharmaceuticals (RXRX.MX) has reported earnings of -9.83495 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login